or
Bookmark and Share
Porphyrin, azaporphyrin, and related fluorescent dyes free of aggregation and serum binding
 
   
Document Number
US Patent 5641878
Issued Date
June 24, 1997
Link
Inventors
Hsu; Mao-Lin (Fountain Valley, CA)
Map
Abstract
Fluorescent dyes which are free of aggregation and serum binding are provided. These dyes are suitable for applications such as fluorescence immunoassays, in vivo imaging and in vivo tumor therapy. The dyes are particularly useful in fluorescence immunoassays of biological samples containing serum. Such dyes have two polyoxyhydrocarbyl moities, one located on either side of a planar molecular structure such as a porphyrin derivative, azaporphyrin derivative, corrin derivative, sapphyrin derivative or porphycene derivative.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
27
Comments:
no comments yet
Owner
Diatron Corporation (San Diego, CA)
Published
June 24, 1997
Application Number
08/333,603
Filed
November 2, 1994
US Classification
540/128   540/121 540/145 540/474
Int'l Classification
C07D   487/00   (20060101)   C09B   47/04   (20060101)   C09B   47/08   (20060101)   C09B   47/00   (20060101)   C09B   47/24   (20060101)   A61K   49/00   (20060101)   C07D   487/22   (20060101)   G01N   33/58   (20060101)  
Examiner
Assistant Examiner
Attorney/Law Firm
Parent Case
This application is a continuation of application Ser. No. 07/701,465, filed May 5, 1991, now abandoned.
USPTO Field of Search
540/121   540/145   540/472   540/128  
Related Patents
6083486 - Intramolecularly-quenched near infrared fluorescent probes - Owned by The General Hospital Corporation (Boston, MA)

An intramolecularly-quenched, near infrared fluorescence probe that emits substantial fluorescence only after interaction with a target tissue (i.e., activation) is disclosed. The probe includes a polymeric backbone and a plurality of near infrared fluorochromes covalently linked to the backbone at fluorescence-quenching interaction-permissive positions separable by enzymatic cleavage at fluorescence activation sites. The probe optionally includes protective chains or fluorochrome spacers, or both. Also disclosed are methods of using the intramolecularly-quenched, near infrared fluorescence probes for in vivo optical imaging.

6592847 - Intramolecularly-quenched near infrared flourescent probes - Owned by The General Hospital Corporation (Boston, MA)

An intramolecularly-quenched, near infrared fluorescence probe that emits substantial fluorescence only after interaction with a target tissue (i.e., activation) is disclosed. The probe includes a polymeric backbone and a plurality of near infrared fluorochromes covalently linked to the backbone at fluorescence-quenching interaction-permissive positions separable by enzymatic cleavage at fluorescence activation sites. The probe optionally includes protective chains or fluorochrome spacers, or both. Also disclosed are methods of using the intramolecularly-quenched, near infrared fluorescence probes for in vivo optical imaging.

7371524 - Substituted azaporphyrins as fluorescence labels - Owned by Hereth; Hannjorg (Baar,CH)

The present invention relates to marker components, fluorescent probes, oligonucleotides, hybridization assays, and immunoassays using such products, and methods for making such products. According to the present invention, detectably labeled marker components are provided that comprise a fluorescent moiety coupled to two small solubilizing groups, one on each side of the molecular plane, said fluorescent moiety having substituents to control net charge so as to reduce or remove the problems of solvent sensitivity and nonspecific binding.

6991775 - Peptide-based multimeric targeted contrast agents - Owned by Epix Medical, Inc. (Cambridge, MA)

Peptides and peptide-targeted multimeric contrast agents are described, as well as methods of making and using the contrast agents.

7238341 - Peptide-based multimeric targeted contrast agents - Owned by Epix Pharmaceuticals, Inc. (Lexington, MA)

Peptides and peptide-targeted multimeric contrast agents are described, as well as methods of making and using the contrast agents.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us